Single-use Technologies for Biopharmaceuticals Market is Projected to Grow at A CAGR of 11.7% During, 2020-2026

ABOUT THIS REPORT

OVERVIEW

Single-use Technologies for Biopharmaceuticals Market was valued at $3,489.0 million by 2019; growing at a CAGR of 11.7% till 2026.

The biopharmaceutical industry is rapidly adopting Single-use technologies for bioprocessing to reduce the risk of cross-contamination. Single-use bioprocessing equipment is designed to be used once. The Single-use bioprocessing equipment is primarily composed of plastic components that have been sealed and sterilized using gamma irradiation. Single-use technology in biopharmaceutical industry includes bioreactors, membrane adsorbers, media bags, mixers, bioprocess containers, and others.

Increasing investments in Single-use technologies for biopharmaceuticals is anticipated to boost the global Single-use technologies for biopharmaceuticals market. The biopharmaceutical industry is rapidly adopting Single-use technologies for bioprocessing in order to reduce the risk of cross-contamination.

The biopharmaceutical companies are investing in Single-use technologies to increase their R&D activities, development capacity, commercialization of new products, and expanding the geographical presence. For instance, Thermo Fisher Scientific Inc. has invested more than $50 million in bioproduction to provide additional capacity for manufacturing Single-use bioprocess container systems. Thermo Fisher’s Single-use technologies are used for sterile liquid-handling applications in the biopharmaceutical industry to ensure quality in the production of biologic drugs and increase productivity. Further, reduce energy, time, and water consumption is a key driving factor of the market. The transition from conventional equipment to the Single-use system results in less energy demand and water consumption. As per the researchers, the biopharmaceutical manufacturing plants which has adopted Single-use technologies experienced a 46% decline in total water consumption and energy consumption as compared to a stainless-steel reactor. Single-use technologies also eliminate the CIP and SIP steps, which leads to at least eight months of shorter project duration. The reduction of time and water consumption has also reduced the related cost.

Single-use Bioreactors, Membrane Adsorbers, Media Bags, Bioprocess Containers, and Others is the type segment of the market scope. By application, the market is divided into Contract Manufacturing Organizations and Biopharmaceutical Manufacturers. The report covers the value of the global market by type and application.

The Single-use bioreactor was dominating the global Single-use technologies for biopharmaceuticals market in 2019, and it is expected to grow in the coming years, owing to the increasing investment to expand the capacity for manufacturing Single-use bioprocess container (BPC) and commercialization of new Single-use bioreactors.

North America, Europe, Asia Pacific, South America, and Middle East & Africa are taken into consideration at the global Single-use technologies for biopharmaceuticals value figures. While North America is further categorized into enhancing the United States, Canada, and Mexico, Europe is split into the United Kingdom, Germany, France, Italy, and Rest of Europe. Asia-Pacific covers India, China, Japan, South Korea, and Rest of Asia Pacific in its scope.

South America is bifurcated into Brazil, Argentina, and Rest of South America, with Middle East & Africa involving GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America Single-use technologies for biopharmaceuticals market was USD XX million in 2019, and it is predicted to reach USD XX million by 2026, growing at a CAGR of XX during the forecast period. North America was dominating the global Single-use technologies for biopharmaceuticals market in 2019, and it is expected to grow in the coming years. Technological advancement and awareness about Single-use technologies for biopharmaceuticals and commercialization of regulatory approved Single-use technologies for biopharmaceuticals are some of the factors driving the North American Single-use technologies for biopharmaceuticals market.

Major players operating in the Single-use technologies for biopharmaceuticals industry include Merck KGaA, Cytiva Lifesciences, Pall Corp, Sartorius Stedim Biotech, Thermo Fisher, Eppendorf, Parker Hannifin, Applikon Biotechnology, Corning Inc, and Repligen Corp.

The commercialization of new Single-use biopharmaceutical products, the increasing investment to expand the additional capacity for manufacturing Single-use bioprocess container (BPC) systems and the collaboration between companies to distribute the Single-use biopharmaceutical products at a global scale are some of the strategies adopted by major players